CRL•benzinga•
Charles River Laboratories Raises FY24 Outlook: Sees Adjusted EPS Of $10.10–$10.30 Vs. $10 Estimate (Prior View: $9.90–$10.20)
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 6, 2024 by benzinga